vimarsana.com

Latest Breaking News On - Transcon growth hormone - Page 1 : vimarsana.com

Ascendis Pharma A/S (NASDAQ:ASND) Q1 2024 Earnings Call Transcript

Operator: Good day, and welcome to the Q1 2024 Ascendis Pharma Earnings Conference Call. At this time, all participants are in a listen-only mode.

Ascendis Pharma A/S : Form 6-K - MarketScreener

Ascendis Pharma A/S (NASDAQ:ASND) Reaches New 52-Week High at $156 84

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s stock price reached a new 52-week high during mid-day trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares. The stock had previously closed at $156.39. Analysts Set New Price Targets Several equities research analysts […]

Ascendis Pharma A/S (NASDAQ:ASND) Sets New 12-Month High at $156 84

Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report)’s share price hit a new 52-week high during trading on Tuesday . The company traded as high as $156.84 and last traded at $155.12, with a volume of 37003 shares traded. The stock had previously closed at $156.39. Analyst Upgrades and Downgrades A number of research firms […]

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2023 Earnings Call Transcript

Ascendis Pharma A/S (NASDAQ:ASND) Q4 2023 Earnings Call Transcript February 7, 2024 Ascendis Pharma A/S isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2023 Ascendis Pharma Earnings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.